Echinocandins are the first-line therapy for invasive Candidozyma auris infections, but the resistance to this drug is increasing. Here, the authors identify a potential target with a distinct mechanism of action for improving echinocandin treatment in C. auris.
- Qingjuan Zhu
- Sien Van de Velde
- Patrick Van Dijck
